VVOS
Vivos Therapeutics, Inc.
2.0200
+0.0000+0%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
-/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
18.16M
P/E (TTM)
-
Basic EPS (TTM)
-1.77
Dividend Yield
0%

Recent Filings

About 

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

CEO
Mr. R. Kirk Huntsman
IPO
12/11/2020
Employees
262
Sector
Healthcare
Industry
Medical Devices